Toll-like receptor agonist induced changes in clonal rat BRIN-BD11 β-cell insulin secretion and signal transduction

Journal of Endocrinology

Volumn 202, Issue 3, 2009, Pages 365-373

  Kiely, Aoife ^a   Robinson, Aisling ^a   McClenaghan, Neville H ^b   Flatt, Peter R ^b   Newsholme, Philip ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INSULIN RECEPTOR SUBSTRATE 1; LIPOPOLYSACCHARIDE; PROTEIN KINASE B; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ALANINE; GLUCOSE; GLUTAMINE; INSULIN;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; INCUBATION TIME; INSULIN RELEASE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SECRETION;

ALANINE; ANIMALS; CALCINEURIN; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GLUTAMINE; INSULIN; INSULIN-SECRETING CELLS; LIPOPOLYSACCHARIDES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 70349331508     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0160     Document Type: Article

References (43)

1. Accili D 2004 Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes 53 1633-1642. (Pubitemid 38857019)
2. Atkinson TJ 2008 Toll-like receptors, transduction-effector pathways and disease diversity: evidence of an immunobiological paradigm explaining all human illness? International Reviews of Immunology 27 255-281.
3. Barry EF, Felquer FA, Powell JA, Biggs L, Stomski FC, Urbani A, Hoffmann P, Wilce MC, Grimbaldeston MA, Lopez AF et al. 2009 14-3-3 SHC scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate PI 3-kinase activation and cell survival. Journal of Biological Chemistry. Published on February 13, 2009 as Manuscript M807637200.
4. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM & Permutt MA 2001 Islet beta cell expression of constitutively active Akt1/PKBa induces striking hypertrophy, hyperplasia, and hyperinsulinemia. Journal of Clinical Investigation 108 1631-1638. (Pubitemid 33144873)
5. Brennan L, Shine A, Hewage C, Malthouse JPG, Brindle K, McClenaghan N, Flatt PR & Newsholme P 2002 A NMR based demonstration of substantial oxidative L-alanine metabolism and L-alanine enhanced glucose metabolism in a clonal pancreatic β-cell line - metabolism of L-alanine is important to the regulation of insulin secretion. Diabetes 51 1714-1721. (Pubitemid 34564282)
6. 13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and gamma-glutamyl cycle activity in a clonal pancreatic beta-cell line. Diabetologia 46 1512-1521.
7. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C et al. 2007 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 1761-1772. (Pubitemid 47025442)
8. Chapman JC, McClenaghan NH, Cosgrove KE, Hashmi MN, Shepherd R, Giesberts AN, White S, Ammala C, Flatt PR & Dunne MJ 1999 ATP-sensitive potassium channels and efaroxan-induced insulin release in the elctrofusion-derived BRIN-BD11 beta-cell line. Diabetes 48 2349-2357. (Pubitemid 30395426)
9. Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA & Rich SS 2005 Type 1 diabetes genetics consortium. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1435 multiplex families. Diabetes 54 2995-3001.
10. Corless M, Kiely A, McClenaghan NH, Flatt PR & Newsholme P 2006 Glutamine regulates expression of key transcription factor, signal transduction, metabolic gene, and protein expression in a clonal pancreatic beta-cell line. Journal of Endocrinology 190 719-727. (Pubitemid 44560247)
11. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL & Kumar S 2007 Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. American Journal of Physiology. Endocrinology and Metabolism 292 E740-E747. (Pubitemid 46411051)
12. Dickson LM & Rhodes CJ 2004 Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? American Journal of Physiology. Endocrinology and Metabolism 287 E192-E198.
13. Dixon G, Nolan J, McClenaghan NH, Flatt PR & Newsholme P 2003 A comparative study of amino acid consumption by rat islet cells and the clonal beta-cell line BRIN-BD11 - the functional significance of L-alanine. Journal of Endocrinology 179 447-454. (Pubitemid 38072096)
14. Drewe J, Beglinger C & Fricker G 2001 Effect of ischemia on intestinal permeability of lipopolysaccharides. European Journal of Clinical Investigation 31 138-144. (Pubitemid 32199907)
15. Fiaschi-Taesch N, Stewart AF & Garcia-Ocana A 2007 Improving islet transplantation by gene delivery of hepatocyte growth factor (HGF) and its downstream target, protein kinase B (PKB)/Akt. Cell Biochemistry and Biophysics 48 191-199.
16. Hamaguchi K, Utsunomiya N, Takaki R, Yoshimatsu H & Sakata T 2003 Cellular interaction between mouse pancreatic alpha-cell and beta-cell lines: possible contact-dependent inhibition of insulin secretion. Experimental Biology and Medicine 228 1227-1233.
17. Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR & Kim SK 2006 Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 443 345-349.
18. Hubert FX, Voisine C, Louvet C, Heslan M & Josien R 2004 Rat plasmacytoid dendritic cells are an abundant subset of MHC class IIC CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of toll-like receptors 7 and 9 and strong responsiveness to CpG. Journal of Immunology 172 7485-7494.
19. Jing L, Wu Q & Wang F 2007 Glutamine induces heat-shock protein and protects against Escherichia coli lipopolysaccharide-induced vascular hyporeactivity in rats. Critical Care 11 R34.
20. Kang YJ, Kusler B, Otsuka M, Hughes M, Suzuki N, Suzuki S, Yeh WC, Akira S, Han J & Jones PP 2007 Calcineurin negatively regulates TLR-mediated activation pathways. Journal of Immunology 179 4598-4607.
21. Kessel A, Toubi E, Pavlotzky E, Mogilner J, Coran AG, Lurie M, Karry R & Sukhotnik I 2008 Treatment with glutamine is associated with downregulation of toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat. Clinical and Experimental Immunology 151 341-347.
22. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA & Kahn CR 1999a Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96 329-339. (Pubitemid 29077587)
23. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, Hanahan D & Kahn CR 1999b Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. Journal of Clinical Investigation 104 R69-R75. (Pubitemid 30053195)
24. Lawrence M, Shao C, Duan L, McGlynn K & Cobb MH 2008 The protein kinases ERK1/2 and their roles in pancreatic beta cells. Acta Physiologica 192 11-17. (Pubitemid 350265365)
25. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N & Hwang DH 2003 Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. Journal of Biological Chemistry 278 37041-37051. (Pubitemid 37175218)
26. McClenaghan NH 2007 Functional insights for understanding and therapy of diabetes physiological regulation of the pancreatic beta-cell. Experimental Physiology 92 481-496.
27. McClenaghan NH & Flatt PR 1999 Engineering cultured insulin-secreting pancreatic beta-cell lines. Journal of Molecular Medicine 77 235-243.
28. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YHA, O'Harte FPM, Yoon T-W, Swanston-Flatt SK & Flatt PR 1996a Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-DB11, produced by electrofusion. Diabetes 45 1132-1140. (Pubitemid 26260168)
29. McClenaghan NH, Barnett CR, O'Harte FPM & Flatt PR 1996b Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic β-cell line. Journal of Endocrinology 15 349-357.
30. Newsholme P, Brennan L & Bender K 2006 Amino acid metabolism, beta cell function and diabetes. Diabetes 55 S39-S47. (Pubitemid 44927031)
31. Oguri S, Motegi K, Iwakura Y & Endo Y 2002 Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice. Clinical and Diagnostic Laboratory Immunology 9 1307-1312. (Pubitemid 35283295)
32. O'Neill LA 2006 How toll-like receptors signal: what we know and what we don't know. Current Opinion in Immunology 18 3-9.
33. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB & Storlien LH 1997 Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46 983-988. (Pubitemid 27220998)
34. Podolin PL, Denny P, Lord CJ, Hill NJ, Todd JA, Peterson LB, Wicker LS & Lyons PA 1997 Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. Journal of Immunology 159 1835-1843. (Pubitemid 127484171)
35. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C et al. 1998 Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 2085-2088. (Pubitemid 29001265)
36. Rock FL, Hardiman G, Timans JC, Kastelein RA & Bazan JF 1998 A family of human receptors structurally related to Drosophila Toll. PNAS 95 588-593.
37. Sherry CL, O'Connor JC, Kramer JM & Freund GG 2007 Augmented lipopolysaccharide-induced TNF-α production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. Journal of Immunology 178 663-670.
38. Takamatsu N 1998 The new colorimetric assay (WST-1) for cellular growth with normal aging and Alzheimer's disease. Nippon Ronen Igakkai Zasshi 35 535-542. (Pubitemid 28433615)
39. Tilg H & Moschen AR 2008 Inflammatory mechanisms in the regulation of insulin resistance. Molecular Medicine 14 222-231.
40. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA et al. 2007 Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56 1986-1998. (Pubitemid 47195825)
41. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A & Birnbaum MJ 2001 Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nature Medicine 7 1133-1137. (Pubitemid 33010022)
42. Vitseva OI, Tanriverdi K, Tchkonia TT, Kirkland JL, McDonnell ME, Apovian CM, Freedman J & Gokce N 2008 Inducible toll-like receptor and NF-κB regulatory pathway expression in human adipose tissue. Obesity 16 932-937. (Pubitemid 351620468)
43. Vives-Pi M, Somoza N, Fernandez-Alvarez J, Vargas F, Caro P, Alba A, Gomis R, Labeta MO & Pujol-Borrell R 2003 Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clinical and Experimental Immunology 133 208-218. (Pubitemid 36918595)